Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-29

Clinical Trial Update: Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks [Phase 4]

View source ↗

Summary

A Phase 4 cohort trial in Uganda comparing artesunate plus amodiaquine (Coarsucam) versus artemether plus lumefantrine (Coartem) for treatment of repeated uncom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amodiaquine (Amodiaquine)
  • Artesunate (artesunate)
  • artemether (artemether)
  • lumefantrine (lumefantrine)

Snippet

Sponsor: Sanofi | Conditions: Malaria | Phase 4 | Status: COMPLETED